000			02147 a2200589 4500
005			20250516174117.0
264		0	_c20140522
008			201405s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0076652 _2doi
040			_aNLM _beng _cNLM
100	1		_aXu, Yong
245	0	0	_aHypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection. _h[electronic resource]
260			_bPloS one _c2013
300			_ae76652 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnesthetics, Inhalation _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCardiotonic Agents _xadministration & dosage
650	0	4	_aCoronary Artery Disease _xetiology
650	0	4	_aDiet
650	0	4	_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors
650	0	4	_aGlycogen Synthase Kinase 3 beta
650	0	4	_aHeart Ventricles _xdrug effects
650	0	4	_aHemodynamics _xdrug effects
650	0	4	_aHypercholesterolemia _xcomplications
650	0	4	_aIschemic Postconditioning
650	0	4	_aMale
650	0	4	_aMethyl Ethers _xadministration & dosage
650	0	4	_aMitogen-Activated Protein Kinase 1 _xmetabolism
650	0	4	_aMitogen-Activated Protein Kinase 3 _xmetabolism
650	0	4	_aMuscular Dystrophies, Limb-Girdle _xmetabolism
650	0	4	_aMyocardial Reperfusion Injury _xdrug therapy
650	0	4	_aMyocardium _xmetabolism
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aRats
650	0	4	_aSevoflurane
700	1		_aMa, Lei-Lei
700	1		_aZhou, Chen
700	1		_aZhang, Fei-Jiang
700	1		_aKong, Fei-Juan
700	1		_aWang, Wen-Na
700	1		_aQian, Ling-Bo
700	1		_aWang, Can-Can
700	1		_aLiu, Xian-Bao
700	1		_aYan, Min
700	1		_aWang, Jian-An
773	0		_tPloS one _gvol. 8 _gno. 10 _gp. e76652
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0076652 _zAvailable from publisher's website
999			_c23170167 _d23170167